Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1997-05-02
1998-09-08
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4242561, 530350, 930200, A61K 39102
Patent
active
058041907
ABSTRACT:
This invention discloses the DNA sequences coding for the Actinobacillus pleuropneumonia hemolysin(s). It further discloses a method of producing the A. pleuropneumoniae hemolysin(s) from recombinant cells. It also provides a method of using the hemolysin(s) antigen as a protective immunogen against porcine pleuropneumonia.
REFERENCES:
patent: 5254340 (1993-10-01), Van Leengoed et al.
Smits, M. A. et al. Infection and Immunity, vol. 59, pp. 4497-4504, Dec. 1991.
Kamp, E.M. et al. Journal of Clinical Microbiology, vol. 27, pp. 1187-1191, May 24, 1989.
Coote, J.G. FEMS Microbiology Reviews, vol. 88, pp. 137-162, 92.
Chang et al., Cloning and Characterization of a Hemolysin Gene from Actinobacillus (Haemophilus) Pleuropneumoniae, DNA, vol. 8, No. 9, pp. 635-647 (1989).
Chang et al., Secretion of the Pasteurella Leukotoxin by Escherichia Coli, FEMS Microbiology Letters 60:169-174 (1989).
Frey and Nicolet, Purification and Partial Characterization of a Hemolysin Produced By Actinobacillus Pleuropneumoniae Type Strain 4074, FEMS Microbiology Letters 55:41-46 (1988).
Maudsley and Kadis, Growth and Hemolysin Production By Haemophilus Pleuropneumoniae Cultivated In A Chemically Defined Medium, Can. J. Microbiol., vol. 32, pp. 801-805 (1986).
Kume et al., Interaction Between Heat-Stable Hemolytic Substance from Haemophilus pleuropneumoniae and Porcine Pulmonary Macrophages In Vitro, Infection and Immunity, vol. 51, No. 2, pp. 563-570 (1986).
Martin et al., Production of RNA-dependent Haemolysin by Haemophilus pleuropneumoniae, Can. J. Microbiol., vol. 31, pp. 456-462 (1985).
Bendixen et al., Toxicity of Haemophilus pleuropneumoniae for Porcine Lung Macrophages, Peripheral Blood Monocytes, and Testicular Cells, Infection and Immunity, vol. 33, No. 3, pp. 673-676 (1981).
Fedorka-Cray et al., "Efficacy of Hemolysin as a Protective Antigen Against Actinobacillus (Haemophilus) Pleuropneumoniae (APP) Infection in Swine," Abstracts of the Annual Meeting, Abstract No. B-37 (1988).
Strathdee et al., "Cloning, Nucleotide Sequence, and Characterization of Genes Encoding the Secretion Function of the Pasteurella Haemolytica Leukotoxin Determinant," Abstract No. 147554c, p. 149 (1989).
Highlander et al DNA 8: 15 (1989).
Lo et al. Infect Imm. 55: 1987 (1987).
Felmlee et al. J. Bact 163: 88 (1989).
Gunnarsson et al. Am J. Vet. Res. 40: 1564-1567, 1979.
Young et al. PNAS 80: 1194, 1983.
Chang Yung-Fu
Struck Douglas K.
Young Ryland F.
Mosher Mary E.
The Texas A&M University System
LandOfFree
Recombinant vaccine for porcine pleuropneumonia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant vaccine for porcine pleuropneumonia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant vaccine for porcine pleuropneumonia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1279619